Background illustration for clinical trials search

Paid Clinical Trials Rochester

Discover 998 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 998

Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders

for

Plasma Cell Disorders

Location: Rochester MN

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06252948

Recruiting

Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)

for

Cardiopulmonary

Location: Rochester MN, Plano TX, Dallas TX, Wilmington DE,

Sponsor: Prolaio

Sex: All

Age: 18+

Code: NCT05678530

Recruiting

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

for

Chronic Lymphocytic Leukemia,

Location: Rochester MN

Sponsor: Mayo Clinic

Sex: All

Age: 0+

Code: NCT06151730

Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

for

Castrate Resistant Prostate Cancer, NUT Carcinoma,

Location: Rochester MN, Houston TX, Boston MA, Jacksonville FL,

Sponsor: Epigenetix, Inc.

Sex: All

Age: 18+

Code: NCT05488548

Phase1, Recruiting

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

for

Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma,

Location: Rochester MN

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04082520

Phase2, Recruiting

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care

for

Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung

Location: Rochester MN

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06482073

Recruiting

Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment

for

Gastrointestinal Complication

Location: Rochester MN, Minneapolis MN, Chicago IL,

Sponsor: Entac Medical Inc.

Sex: All

Age: 18 - 70+

Code: NCT04880473

Recruiting

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

for

Advanced Fallopian Tube Carcinoma,

Location: Rochester MN, Jacksonville FL, Scottsdale AZ

Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT06639074

Phase2, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Location: Rochester MN, Clive IA, Omaha NE, Quincy IL, Lisle IL,

Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase3, Recruiting

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

for

Metastatic Digestive System Neuroendocrine Tumor G1,

Location: Rochester MN, Ankeny IA, Clive IA, Des Moines IA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05773274

Phase2, Recruiting

Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer

for

Breast Carcinoma, Metastatic Breast Carcinoma,

Location: Rochester MN

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06217874

Recruiting

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

for

Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Location: Rochester MN, Chicago IL, Ann Arbor MI, Cincinnati OH,

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 0

Code: NCT04786574

Phase3, Recruiting

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

for

LVAD, Frailty, GI Bleed, Right Heart Failure, Infections,

Location: Rochester MN, Chicago IL, Gainesville FL,

Sponsor: International Consortium of Circulatory Assist Clinicians

Sex: All

Age: 18 - 70+

Code: NCT06039176

Recruiting

Pulmonary Hypertension Association Registry

for

Pulmonary Arterial Hypertension,

Location: Rochester MN, Minneapolis MN, Madison WI, Iowa City IA,

Sponsor: Pulmonary Hypertension Association, Inc.

Sex: All

Age: 0+

Code: NCT04071327

Recruiting

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

for

Childhood Malignant Solid Neoplasm,

Location: Rochester MN

Sponsor: Mayo Clinic

Sex: All

Age: 0 - 17

Code: NCT06915727

Phase3, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for

Clonal Mast Cell Disease, KIT D816V Mutation,

Location: Rochester MN, Omaha NE, Evanston IL, Normal IL,

Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

for

Cancer, Predictive Cancer Model, Effects of Chemotherapy

Location: Rochester MN, Durham NC, Houston TX

Sponsor: Known Medicine, Inc.

Sex: All

Age: 18+

Code: NCT05338073

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

for

Acute Respiratory Distress Syndrome (ARDS), ARDS,

Location: Rochester MN, Peoria IL, Ann Arbor MI, Toledo OH,

Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06703073

Phase2, Recruiting

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

for

Large B-Cell Lymphoma With IRF4 Rearrangement,

Location: Rochester MN, Albert Lea MN, La Crosse WI,

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06834373

Phase2, Recruiting

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

for

Malignant Solid Neoplasm,

Location: Rochester MN, Bethesda MD, Jacksonville FL,

Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03750227

Phase3, Recruiting

Paid Clinical Trials Rochester

Filter results

Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders

Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Interested in new trials?

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care

Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

Pulmonary Hypertension Association Registry

An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors